{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T10:28:44Z","timestamp":1793442524518,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82174095"],"award-info":[{"award-number":["82174095"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004863","name":"Zhejiang Chinese Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004863","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LZ22H290001"],"award-info":[{"award-number":["LZ22H290001"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.phymed.2025.156514","type":"journal-article","created":{"date-parts":[[2025,2,16]],"date-time":"2025-02-16T01:28:56Z","timestamp":1739669336000},"page":"156514","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Celastrol-loaded ginsenoside Rg3 liposomes enhance anti-programmed death ligand 1 immunotherapy by inducing immunogenic cell death in triple-negative breast cancer"],"prefix":"10.1016","volume":"139","author":[{"given":"Jingyi","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingbin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ninghui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanyu","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningchao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiushuang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.phymed.2025.156514_bib0001","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1158\/0008-5472.CAN-20-2990","article-title":"Macrophage-based approaches for cancer immunotherapy","volume":"81","author":"Anderson","year":"2021","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.phymed.2025.156514_bib0002","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s00262-020-02740-3","article-title":"Stress relief for cancer immunotherapy: implications for the ER stress response in tumor immunity","volume":"70","author":"Andrews","year":"2021","journal-title":"Cancer Immunol. Immunother. CII"},{"issue":"5","key":"10.1016\/j.phymed.2025.156514_bib0003","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/s41591-021-01323-8","article-title":"A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer","volume":"27","author":"Bassez","year":"2021","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.phymed.2025.156514_bib0004","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1038\/s41418-017-0044-9","article-title":"eIF2\u03b1 phosphorylation is pathognomonic for immunogenic cell death","volume":"25","author":"Bezu","year":"2018","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.phymed.2025.156514_bib0005","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/s41392-023-01658-3","article-title":"Tumor-repopulating cell-derived microparticles elicit cascade amplification of chemotherapy-induced antitumor immunity to boost anti-PD-1 therapy","volume":"8","author":"Bie","year":"2023","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"Pt 2","key":"10.1016\/j.phymed.2025.156514_bib0006","article-title":"Hypoxia-responsive immunostimulatory nanomedicines synergize with checkpoint blockade immunotherapy for potentiating cancer Immunotherapy","volume":"451","author":"Chen","year":"2023","journal-title":"Chem. Eng. J."},{"issue":"2","key":"10.1016\/j.phymed.2025.156514_bib0007","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41568-020-00312-2","article-title":"Endoplasmic reticulum stress signals in the tumour and its microenvironment","volume":"21","author":"Chen","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.phymed.2025.156514_bib0008","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jgr.2017.08.003","article-title":"Enhanced Rg3 negatively regulates Th1 cell responses","volume":"43","author":"Cho","year":"2019","journal-title":"J. Ginseng. Res."},{"issue":"9","key":"10.1016\/j.phymed.2025.156514_bib0009","doi-asserted-by":"crossref","first-page":"6246","DOI":"10.1021\/acs.nanolett.0c00713","article-title":"Eliciting immunogenic cell death via a unitized nanoinducer","volume":"20","author":"Dai","year":"2020","journal-title":"Nano Lett."},{"issue":"4","key":"10.1016\/j.phymed.2025.156514_bib0010","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/oncolo\/oyad025","article-title":"Variable landscape of PD-L1 expression in breast carcinoma as detected by the DAKO 22C3 immunohistochemistry assay","volume":"28","author":"Danziger","year":"2023","journal-title":"Oncologist"},{"issue":"2","key":"10.1016\/j.phymed.2025.156514_bib0011","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41419-019-1408-5","article-title":"ER stress sensor, glucose regulatory protein 78 (GRP78) regulates redox status in pancreatic cancer thereby maintaining \"stemness\"","volume":"10","author":"Dauer","year":"2019","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.phymed.2025.156514_bib0012","doi-asserted-by":"crossref","DOI":"10.1002\/advs.201801868","article-title":"Tumors and their microenvironment dual-targeting chemotherapy with local Immune adjuvant therapy for effective antitumor immunity against breast cancer","volume":"6","author":"Deng","year":"2019","journal-title":"Adv. Sci."},{"issue":"1","key":"10.1016\/j.phymed.2025.156514_bib0013","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S1470-2045(17)30904-X","article-title":"Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy","volume":"19","author":"Denkert","year":"2018","journal-title":"Lancet Oncol."},{"issue":"6","key":"10.1016\/j.phymed.2025.156514_bib0014","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41571-021-00473-5","article-title":"PD-L1 as a biomarker of response to immune-checkpoint inhibitors","volume":"18","author":"Doroshow","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.phymed.2025.156514_bib0015","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.jconrel.2020.10.055","article-title":"Cell surface GRP78: an emerging imaging marker and therapeutic target for cancer","volume":"328","author":"Farshbaf","year":"2020","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"issue":"11","key":"10.1016\/j.phymed.2025.156514_bib0016","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/s41419-020-03221-2","article-title":"Detection of immunogenic cell death and its relevance for cancer therapy","volume":"11","author":"Fucikova","year":"2020","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.phymed.2025.156514_bib0017","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.bbcan.2017.04.002","article-title":"Linking tumor glycolysis and immune evasion in cancer: emerging concepts and therapeutic opportunities","volume":"1868","author":"Ganapathy-Kanniappan","year":"2017","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"D1","key":"10.1016\/j.phymed.2025.156514_bib0018","doi-asserted-by":"crossref","first-page":"D330","DOI":"10.1093\/nar\/gky1055","volume":"47","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"10","key":"10.1016\/j.phymed.2025.156514_bib0019","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1158\/2159-8290.CD-17-0222","article-title":"Immune escape in breast cancer during in situ to invasive carcinoma transition","volume":"7","author":"Gil Del Alcazar","year":"2017","journal-title":"Cancer Discov."},{"issue":"7","key":"10.1016\/j.phymed.2025.156514_bib0020","first-page":"513","article-title":"Research progress of adverse events related to PD-1\/PD-L1 inhibitors based combination therapy]","volume":"24","author":"Guo","year":"2021","journal-title":"Zhongguo Fei Ai Za Zhi"},{"issue":"1","key":"10.1016\/j.phymed.2025.156514_bib0021","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: kyoto encyclopedia of genes and genomes","volume":"28","author":"Kanehisa","year":"2000","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.phymed.2025.156514_bib0022","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-40996-2","article-title":"A photo-triggered self-accelerated nanoplatform for multifunctional image-guided combination cancer immunotherapy","volume":"14","author":"Kang","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.phymed.2025.156514_bib0023","doi-asserted-by":"crossref","first-page":"5216","DOI":"10.1038\/s41467-023-40996-2","article-title":"A photo-triggered self-accelerated nanoplatform for multifunctional image-guided combination cancer immunotherapy","volume":"14","author":"Kang","year":"2023","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.phymed.2025.156514_bib0024","doi-asserted-by":"crossref","first-page":"479","DOI":"10.6004\/jnccn.2020.7554","article-title":"Role of immunotherapy in triple-negative breast cancer","volume":"18","author":"Keenan","year":"2020","journal-title":"J. Natl. Compr. Cancer Netw."},{"issue":"12","key":"10.1016\/j.phymed.2025.156514_bib0025","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nrc3380","article-title":"Immunogenic cell death and DAMPs in cancer therapy","volume":"12","author":"Krysko","year":"2012","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.phymed.2025.156514_bib0026","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12915-021-01034-z","article-title":"Single-cell transcriptomics reveals the effect of PD-L1\/TGF-\u03b2 blockade on the tumor microenvironment","volume":"19","author":"Lim","year":"2021","journal-title":"BMC Biol."},{"issue":"1","key":"10.1016\/j.phymed.2025.156514_bib0027","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1038\/s41467-019-09415-3","article-title":"Crizotinib-induced immunogenic cell death in non-small cell lung cancer","volume":"10","author":"Liu","year":"2019","journal-title":"Nat. Commun."},{"issue":"31","key":"10.1016\/j.phymed.2025.156514_bib0028","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2303448120","article-title":"ER chaperone GRP78\/BiP translocates to the nucleus under stress and acts as a transcriptional regulator","volume":"120","author":"Liu","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.phymed.2025.156514_bib0029","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1021\/jacs.1c11886","article-title":"ER-targeting cyanine dye as an NIR photoinducer to efficiently trigger photoimmunogenic cancer cell death","volume":"144","author":"Ma","year":"2022","journal-title":"J. Am. Chem. Soc."},{"issue":"10","key":"10.1016\/j.phymed.2025.156514_bib0030","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/onc.2010.500","article-title":"Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress","volume":"30","author":"Martins","year":"2011","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.phymed.2025.156514_bib0031","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1158\/2326-6066.CIR-13-0127","article-title":"PD-L1 expression in triple-negative breast cancer","volume":"2","author":"Mittendorf","year":"2014","journal-title":"Cancer Immunol. Res."},{"issue":"1","key":"10.1016\/j.phymed.2025.156514_bib0032","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2217\/17435889.4.1.105","article-title":"Targeted nanomedicines: effective treatment modalities for cancer, AIDS and brain disorders","volume":"4","author":"Muthu","year":"2009","journal-title":"Nanomedicine"},{"issue":"1","key":"10.1016\/j.phymed.2025.156514_bib0033","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.1038\/s41467-020-19192-z","article-title":"Overcoming primary and acquired resistance to anti-PD-L1 therapy by induction and activation of tumor-residing cDC1s","volume":"11","author":"Oba","year":"2020","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.phymed.2025.156514_bib0034","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1038\/s41467-020-15364-z","article-title":"NPM1 upregulates the transcription of PD-L1 and suppresses T cell activity in triple-negative breast cancer","volume":"11","author":"Qin","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phymed.2025.156514_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120604","article-title":"Celastrol nanoemulsion induces immunogenicity and downregulates PD-L1 to boost abscopal effect in melanoma therapy","volume":"269","author":"Qiu","year":"2021","journal-title":"Biomaterials"},{"issue":"12","key":"10.1016\/j.phymed.2025.156514_bib0036","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/d41573-023-00179-6","article-title":"PD1\/PDL1 clinical trials adapt to a growing landscape of patients resistant to PDx","volume":"22","author":"Saez-Iba\u00f1ez","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.phymed.2025.156514_bib0037","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.phymed.2025.156514_bib0038","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.apsb.2021.06.005","article-title":"A cyclodextrin-based nanoformulation achieves co-delivery of ginsenoside Rg3 and quercetin for chemo-immunotherapy in colorectal cancer","volume":"12","author":"Sun","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"3","key":"10.1016\/j.phymed.2025.156514_bib0039","first-page":"209","article-title":"Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.phymed.2025.156514_bib0040","doi-asserted-by":"crossref","first-page":"11923","DOI":"10.1038\/s41598-023-39076-8","article-title":"Developing a dual VEGF\/PDL1 inhibitor based on high-affinity scFv heterodimers as an anti-cancer therapeutic strategy","volume":"13","author":"Tzuri","year":"2023","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.phymed.2025.156514_bib0041","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.celrep.2016.09.008","article-title":"Mitochondrial dysfunction prevents repolarization of inflammatory macrophages","volume":"17","author":"Van den Bossche","year":"2016","journal-title":"Cell Rep."},{"issue":"34","key":"10.1016\/j.phymed.2025.156514_bib0042","doi-asserted-by":"crossref","first-page":"eabq4722","DOI":"10.1126\/sciadv.abq4722","article-title":"Regulation of PD-L1 through direct binding of cholesterol to CRAC motifs","volume":"8","author":"Wang","year":"2022","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.phymed.2025.156514_bib0043","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s40824-022-00329-8","article-title":"Ginsenoside Rg3 nanoparticles with permeation enhancing based chitosan derivatives were encapsulated with doxorubicin by thermosensitive hydrogel and anti-cancer evaluation of peritumoral hydrogel injection combined with PD-L1 antibody","volume":"26","author":"Wu","year":"2022","journal-title":"Biomater. Res."},{"issue":"6","key":"10.1016\/j.phymed.2025.156514_bib0044","doi-asserted-by":"crossref","first-page":"eabj1262","DOI":"10.1126\/sciadv.abj1262","article-title":"Versatile ginsenoside Rg3 liposomes inhibit tumor metastasis by capturing circulating tumor cells and destroying metastatic niches","volume":"8","author":"Xia","year":"2022","journal-title":"Sci. Adv."},{"issue":"5","key":"10.1016\/j.phymed.2025.156514_bib0046","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41571-022-00601-9","article-title":"Mechanisms regulating PD-L1 expression in cancers and associated opportunities for novel small-molecule therapeutics","volume":"19","author":"Yamaguchi","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.phymed.2025.156514_bib0047","doi-asserted-by":"crossref","first-page":"4758","DOI":"10.1158\/0008-5472.CAN-05-4529","article-title":"Celastrol, a triterpene extracted from the Chinese \"Thunder of God Vine,\" is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice","volume":"66","author":"Yang","year":"2006","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.phymed.2025.156514_bib0048","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/j.cmet.2022.10.010","article-title":"Cancer cell-intrinsic XBP1 drives immunosuppressive reprogramming of intratumoral myeloid cells by promoting cholesterol production","volume":"34","author":"Yang","year":"2022","journal-title":"Cell Metab."},{"issue":"41","key":"10.1016\/j.phymed.2025.156514_bib0049","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202206915","article-title":"A peritumorally injected immunomodulating adjuvant elicits robust and safe metalloimmunotherapy against solid tumors","volume":"34","author":"Zhang","year":"2022","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.phymed.2025.156514_bib0050","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1186\/s12885-021-08763-y","article-title":"Co-expression and prognosis analyses of GLUT1-4 and RB1 in breast cancer","volume":"21","author":"Zhang","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.phymed.2025.156514_bib0051","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jconrel.2023.01.075","article-title":"Engineering nanoparticles boost TNBC therapy by CD24 blockade and mitochondrial dynamics regulation","volume":"355","author":"Zhao","year":"2023","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.phymed.2025.156514_bib0052","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1186\/s12967-022-03741-9","article-title":"Celastrol elicits antitumor effects by inhibiting the STAT3 pathway through ROS accumulation in non-small cell lung cancer","volume":"20","author":"Zhao","year":"2022","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.phymed.2025.156514_bib0053","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120546","article-title":"Pancreatic cancer-targeting exosomes for enhancing immunotherapy and reprogramming tumor microenvironment","volume":"268","author":"Zhou","year":"2021","journal-title":"Biomaterials"},{"issue":"10","key":"10.1016\/j.phymed.2025.156514_bib0054","first-page":"742","article-title":"[Research progress of anti-PD-1\/PD-L1 therapy for non-small cell lung cancer with EGFR mutation]","volume":"25","author":"Zhu","year":"2022","journal-title":"Zhongguo Fei Ai Za Zhi"}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711325001552?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711325001552?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T13:19:45Z","timestamp":1774963185000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711325001552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":53,"alternative-id":["S0944711325001552"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2025.156514","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Celastrol-loaded ginsenoside Rg3 liposomes enhance anti-programmed death ligand 1 immunotherapy by inducing immunogenic cell death in triple-negative breast cancer","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2025.156514","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156514"}}